Superficial and deep incisional surgical site infections (SSIs) for high risk patients in Class I and Class II wounds Post-operative seroma Dehiscence The development of post-operative surgical site ...
The clearance was based on data from 25 clinical studies which included 5560 patients. The Food and Drug Administration (FDA) has cleared Smith+Nephew’s PICO 7 and PICO 14 Single Use Negative Pressure ...
Smith & Nephew plc added new indications for use of its Pico 7 and Pico 14 single-use negative pressure wound therapy (sNPWT) systems. The FDA cleared the London-based device maker’s systems for ...
The development of post-operative surgical site complications (SSCs), such as surgical wound dehiscence, are a substantial burden for patients and healthcare systems, globally1. Postoperative wound ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback